[Therapeutic effect of heparin and its combination with sigetin in experimental utero-placental circulatory disorders].
D000818:Animals; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D002682:Chinchilla; D004220:Disulfides / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004968:Estrogens, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D010920:Placenta / Q000098:blood supply*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011817:Rabbits; D014590:Uterine Contraction / Q000187:drug effects; D014599:Uterus / Q000098:blood supply*
D001557:Benzenesulfonates; D004220:Disulfides; D004968:Estrogens, Non-Steroidal; C001770:sigetin; D006493:Heparin
Lechebnoe vliianie geparina i geparina v sochetanii s sigetinom pri éksperimental'nom narushenii matochno-platsentarnogo krovoobrashcheniia